Site Selection
We move quickly from sponsor discussion into site selection so feasibility work begins without delay.
Pharmaceutical Sponsors & CROs
Clinical Activation
ARRI uses a focused start-up process to move from site selection to study activation quickly while keeping compliance and sponsor coordination intact.
Start-Up Process
Efficient clinical trial activation
The startup process is an important part of the clinical trial and delays can have a huge impact on the cost of a study and ultimately the cost to develop a drug. At African Renal Research Institute, we have an efficient start up process. From site selection to study activation, it takes average of 6 weeks. We use central IRB to expedite start-up process. In addition, contract, budget, and regulatory all can be done in parallel.
Central IRB
We use central IRB pathways to expedite study start-up and reduce approval bottlenecks.
Contract and Budget
Contracting and budget negotiations run in parallel with other activation steps to save time.
Regulatory Readiness
Regulatory documents and study activation requirements are prepared alongside budget and contract work.
Average 6 Weeks
From site selection to study activation, our average startup timeline is approximately 6 weeks.
Sponsor Partnerships
Ready to activate a study?
ARRI can help you scope timelines, start-up requirements, and next steps for renal studies across Africa.